Delivery Order SPE2DB24D9802-SPE2DB25FJLCQ
Award Date 8/25/25
Potential Completion Date 8/26/25
Potential Value $1.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,306.26 under an indefinite delivery contract with the Defense Logistics Agency to supply Letrozole 2.5 mg tablets 30s. The delivery order was awarded on December 1, 2023 and is to be completed by December 4, 2023. DMS Pharmaceutical Group Inc. will provide the pharmaceutical items to Defense Logistics Agency Troop Support Medical facilities located in Park Ridge, Illinois. No set-aside designation was applied...
- The Defense Logistics Agency (DLA) awarded a $1,145.15 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 30. The contract, which is a firm fixed price delivery order with no set-aside designation, is scheduled for completion by July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement action and reflects AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units. This competitively awarded, non-set-aside contract carries a firm fixed price ceiling value of $2,739.96 and is scheduled for completion by August 20, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units, with a contract ceiling value of $2,163.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating the award was made...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $1,081.68, for the supply of Letrozole 2.5 mg tablets in a quantity of 90 units. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of August 6, 2025. The award was issued on August 5, 2025, with performance to be executed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Letrozole is a...
- This is a firm fixed-price delivery order for FEMARA 2.5 mg tablets, awarded by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $3,000.28 contract has an ultimate completion date of January 26, 2022 and is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units. This non-set-aside, competitively awarded contract has a ceiling value of $1,528.52 and is structured as a firm fixed-price delivery order with an ultimate completion date of July 21, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a discrete...
- The Defense Logistics Agency awarded a $3,725.44 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Letrozole 2.5 mg tablets (90-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 29, 2025, to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Letrozole is an aromatase inhibitor commonly used in hormone therapy for breast cancer treatment, reflecting the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 90 tablets of Letrozole 2.5 mg with a ceiling value of $1,647.32. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 14, 2025. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania. This award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Letrozole 2.5mg (90-count supply) valued at $6,490.08 under a firm fixed price contract type. The award was made on July 24, 2025, with an ultimate completion date of the same day, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in the same...